Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects

Authors: Boyle, Julia1; Eriksson, Malin1; Stanley, Neil1; Fujita, Tomoe2; Kumagi, Yuji2

Source: Current Medical Research and Opinion, Volume 22, Number 7, July 2006 , pp. 1343-1351(9)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objectives: To evaluate the acute effects of two histamine H1-receptor antagonists on nocturnal sleep architecture and on next day cognitive function and psychomotor performance.

Methods: This was a single-site, randomized, double-blind, 3-way crossover study, comparing the effects of a single dose of chlorpheniramine (6mg), fexofenadine (120mg) and placebo in 18 healthy (male and female) Japanese volunteers aged 20-55 years. Volunteers were resident for 3 days and each period was separated by a minimum 5-day washout period. The three treatments were administered at 23.00h. Overnight sleep was measured from 23.00h to 07.00h using polysomnography. Residual effects were studied at 07.00h and 9.00h the next morning, with the latency to sleep (sleep latency test) measured at 09.30h.

Results: Compared with placebo, chlorpheniramine increased the latencies to sleep onset and rapid eye movement (REM) sleep (p ≤ 0.05 for both), and reduced the duration of REM sleep (p ≤ 0.01), but this was not observed with fexofenadine. As far as residual effects the next morning were concerned there were decrements in performance with chlorpheniramine, but not with fexofenadine. Chlorpheniramine 6 mg impaired divided attention (p < 0.001), vigilance (p < 0.05), working memory (p < 0.0001) and sensori-motor performance (p < 0.01), and the latency to daytime sleep was reduced (p < 0.0001). Six adverse events possibly related to study medication were reported during the study, three of which were related to placebo, two to fexofenadine and one to chlorpheniramine.

Conclusion: These findings suggest that a single nocturnal dose of fexofenadine has advantages over the first-generation antihistamine chlorpheniramine, being free of disruption of night-time sleep and detrimental effects on cognitive performance the next day. It is likely that this advantage will remain with chronic ingestion, but this would need to be confirmed.

Keywords: ANTIHISTAMINES; CHLORPHENIRAMINE; FEXOFENADINE; JAPANESE; RESIDUAL EFFECTS; SLEEP

Document Type: Research article

DOI: 10.1185/030079906X112660

Affiliations: 1: HPRU Medical Research Centre, University of Surrey, Guildford, UK 2: Division of Clinical Trials. Clinical Investigation Centre, Kitasato University East Hospital, Japan

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A